Eledon Pharmaceuticals, Inc. Stock Split Ratio
Eledon Pharmaceuticals, Inc. (ELDN) reported Stock Split Ratio of 5.56% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-24
- Eledon Pharmaceuticals, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2021 was 5.56%, a 0.00% change from fiscal 2020.
- Eledon Pharmaceuticals, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 5.56%, a 50.00% decline from fiscal 2019.
- Eledon Pharmaceuticals, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2019 was 11.11%, a 0.00% change from fiscal 2018.
- Eledon Pharmaceuticals, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 11.11%, a 0.00% change from fiscal 2017.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|
| 2021-12-31 | 5.56% 10-K · filed 2022-03-24 | |
| 2020-12-31 | 5.56% 10-K · filed 2021-03-31 | |
| 2019-12-31 | 11.11% 10-K · filed 2020-03-17 | |
| 2018-12-31 | 11.11% 10-K · filed 2019-03-28 | |
| 2017-12-31 | 11.11% 10-K · filed 2018-04-02 | |
| 2014-08-29 | 9.50% 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |